Literature DB >> 29785760

Thyroid function in hidradenitis suppurativa: a population-based cross-sectional study from Denmark.

I M Miller1,2, G Vinding2,3, H A Sørensen2,4, H Rytgaard5, U B Mogensen5, C Ellervik6,7, G B Jemec1,2.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease. Numerous studies have associated HS with obesity, and recently with metabolic syndrome (MetS). Both obesity and MetS are linked with metabolic changes. Thyroid hormones play a central role in metabolism and exert pleiotropic effects on adipogenesis and the basal metabolism of lipids and glucose. We hypothesized that patients with HS have an altered or dysfunctional metabolism expressed as thyroid function. AIM: To investigate thyroid function in individuals with HS compared with healthy controls (HCs).
METHODS: We conducted a retrospective comparative cross-sectional study using blood samples and questionnaire-based self-reported information to assess thyroid function.
RESULTS: Our study comprised 430 patients in a population-based HS group, and 20 780 HCs. The age/sex-adjusted analysis showed a significantly lower level (P < 0.001) of thyroid-stimulating hormone (TSH) and a significantly higher level (P < 0.0001) of total triiodothyronine (tT3) for the HS compared with the HC group. The age/sex-adjusted analysis also showed a significant association between clinical hyperthyroidism and HS (an OR = 1.91, 95% CI 1.19-3.07; P = 0.02). When this analysis was adjusted further for the potential confounders of body mass index, smoking and oral contraception, the results remained significant.
CONCLUSION: This study suggests that HS is associated with hyperthyroidism. Hyperthyroidism may indicate an altered or dysfunctional metabolism.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29785760     DOI: 10.1111/ced.13606

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Risk of Hidradenitis Suppurativa Comorbidities Over Time: A Prospective Cohort Study of Danish Blood Donors.

Authors:  Rune Kjærsgaard Andersen; Isabella Charlotte Loft; Kristoffer Burgdorf; Christian Erikstrup; Ole B Pedersen; Gregor B E Jemec
Journal:  Acta Derm Venereol       Date:  2021-01-20       Impact factor: 3.875

Review 2.  Comorbidities of hidradenitis suppurativa: A review of the literature.

Authors:  Alexander Cartron; Marcia S Driscoll
Journal:  Int J Womens Dermatol       Date:  2019-07-02

Review 3.  Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

Authors:  Amit Garg; Neeta Malviya; Andrew Strunk; Shari Wright; Afsaneh Alavi; Raed Alhusayen; Ali Alikhan; Steven D Daveluy; Isabelle Delorme; Noah Goldfarb; Wayne Gulliver; Iltefat Hamzavi; Tarannum Jaleel; Alexa B Kimball; Joslyn S Kirby; Mark G Kirchhof; Janice Lester; Hadar Lev-Tov; Michelle A Lowes; Robert Micheletti; Lauren A Orenstein; Vincent Piguet; Christopher Sayed; Jerry Tan; Haley B Naik
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

4.  The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.

Authors:  Alexandra B Kimball; Murali Sundaram; Genevieve Gauthier; Annie Guérin; Irina Pivneva; Rakesh Singh; Arijit Ganguli
Journal:  Dermatol Ther (Heidelb)       Date:  2018-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.